刍议依达拉奉对于脑干出血患者治疗中的临床效果.docVIP

刍议依达拉奉对于脑干出血患者治疗中的临床效果 　　[摘要] 目的 研究分析依达拉奉用于脑干出血患者治疗中的临床效果。方法 方便选取该院神经内科收治的2012年12月―2015年12月60例脑干出血患者，严格按照随机数表法分为B组以及A组，每组30例，A组患者使用依达拉奉治疗，B组则使用常规治疗，对两组患者的治疗效果进行比较，同时比较分析两组患者的不良反应发生情况。结果 在完成分析之后，A组患者的治疗总有效率为86.67%，B组患者的治疗总有效率为60.00%，B组患者总计治疗的总有效率明显比A组患者的低，P值小于0.05。B组的不良反应发生率总计为13.33%，A组的不良反应发生率总计为3.33%，B组不良反应发生率明显高于A组，P值小于0.05。 结论 在脑干出血患者治疗过程中，使用依达拉奉治疗可以取得非常显著的效果，值得进一步推广使用。 　　[关键词] 依达拉奉；脑干出血；治疗效果 　　[中图分类号] R743 [文献标识码] A [文章编号] 1674-0742（2016）08（a）-0124-03 　　[Abstract] Objective Analysis on the clinical effect of edaravone in the treatment of patients with brainstem hemorrhage. Methods Convenient selection from December 2012 to December 2015， 60 patients with brainstem hemorrhage were selected， hemorrhage were divided into according to the treatment group and the treatment group， 30 cases of each group，research in the treatment group was treated with edaravone， reference therapy group use routine treatment， the treatment effect of two groups of patients and its adverse reactions occurrence were analyzed and compared Results Study on treatment group total treatment the total efficiency was 86.67%， with reference to the treatment group patients with a total of treatment the total efficiency was 60.00%， with reference to the treatment group total treatment of total efficiency obviously than the treatment group were low，P 0.05. According to the adverse reaction rate of treatment group total was 13.33%， the adverse reaction rate of the treatment group for a total of 3.33%， according to the incidence of adverse reaction in treatment group was significantly higher than that of the treatment group，P0.05. Conclusion In the brainstem hemorrhage patients during the treatment， the use of edaravone treatment can achieve very significant results，worthy of further promotion. 　　[Key words]Edaravone； Brainstem hemorrhage； Treatment effect 　　该研究旨在探索依达拉奉治疗脑干出血的临床疗效。在分析相关文献的基础上方便选取该院2012年12月―2015年12月期间收治的60例脑干出血患者作为该次分析的主体对象，对上述选取的60例患者有计划性的分组研究，经过研究得到，使用依达拉奉治疗可以取得非常显著的效果，可以促使患者